Mutations in the RNase L gene were found to contribute to enhanced cell migration and invasion, and knockdown of RNase L in human prostate cancer cell line PC3 resulted in increase of tumour growth rate and metastases spreading in vivo (Banerjee et al., 2015; Dayal et al., 2017; Table 3). The gene discussed is RNASEL; the disease is prostate carcinoma.